Frontlight ResearchEarly access
Trial site
Tartu
- 4running trials
- 4closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Familial hypercholesterolaemia3 trials
- Multiple sclerosis3 trials
- Coronary artery disease2 trials
- Gastric and oesophageal cancer1 trial
- Osteoarthritis1 trial
- Peripheral artery disease1 trial
- Stroke1 trial
- Phase
- Phase 36 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Active, not recruiting3 trials
- Completed3 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals8 trials
Running trials
Recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple sclerosis1 recruiting
Closed trials
Completed
Terminated
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026